Risk factors for early mortality after hepatectomy for hepatocellular carcinoma. 2016

Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
aDepartment of Surgery, Chang Gung Memorial Hospital, Linkou bCollege of Medicine, Chang Gung University, Guishan, Taoyuan cGraduate Institute of Clinical Medical Sciences, Chang Gung University, Guishan, Taoyuan dDepartment of Anesthesiology,Chang Gung Memorial Hospital, Linkou eDepartment of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou, Taiwan (R.O.C.).

Despite advances in surgical technique and medical care, liver resection for hepatocellular carcinoma (HCC) remains a high-risk major operation. The present study evaluated the risk factors for early mortality after hepatectomy.We retrospectively reviewed records of patients undergoing liver resection for HCC between 1983 and 2015. A point score (Risk Assessment for early Mortality (RAM) score) for hepatectomy was developed based on multivariate analyses.Three hundred eighty-three patients (11.3%) expired within 6 months after the operation. Logistic regression analyses identified that operative duration >270 minutes and blood loss >800 cc were significant predictors of major surgical complications (P = 0.013 and 0.002, respectively). On the other hand, diabetes mellitus, albumin ≤3.5 g/dL, α-fetoprotein (AFP) >200 ng/mL, major surgical procedure, blood loss >800 cc, and major surgical complications were independent risk factors for early mortality after hepatectomy (P = 0.019, <0.001, <0.001, 0.006, 0.018, and <0.001, respectively). Risk Assessment for early Mortality score (RAM score) identified 3 subgroups of patients with distinct 6-month mortality rate, with Class III (score 10) having highest risk of early mortality.Our study demonstrated that meticulous surgical techniques to minimize blood loss and avoid prolonged operative time may help decrease the occurrence of major surgical complications. In addition to major surgical complications, diabetes mellitus, hypoalbuminemia, high AFP, massive blood loss, and major surgical procedure are also associated with early mortality after liver resection. Further study is warranted to validate the utility of RAM score as a bedside scoring system to predict postoperative outcome.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
January 2003, The British journal of surgery,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
October 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
June 2014, Annals of surgical treatment and research,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
March 2016, Surgical oncology,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
July 2007, American journal of surgery,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
October 2013, Hepato-gastroenterology,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
January 2004, Hepato-gastroenterology,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
January 2011, Hepato-gastroenterology,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
October 1994, Hepato-gastroenterology,
Chao-Wei Lee, and Hsin-I Tsai, and Chang-Mu Sung, and Chun-Wei Chen, and Shu-Wei Huang, and Wen-Juei Jeng, and Tsung-Han Wu, and Kun-Ming Chan, and Ming-Chin Yu, and Wei-Chen Lee, and Miin-Fu Chen
November 2014, The American surgeon,
Copied contents to your clipboard!